We diagnosed this hepatic tumor as a BDA based on the presence of Glissonian sheath within the tumor, positive CK7 and negative p53 immunohistochemistry, and a lower proliferative rate inferred from Ki-67 expression in the tumor cells. This evidence concerns the gene TP53 and neoplasm.